title: Fetal programming alters reactive oxygen species production in sheep cardiac mitochondria.
abstract: Exposure to an adverse intrauterine environment is recognized as an important risk factor for the development of cardiovascular disease later in life. Although oxidative stress has been proposed as a mechanism for the fetal programming phenotype, the role of mitochondrial O(2)(*-) (superoxide radical) production has not been explored. To determine whether mitochondrial ROS (reactive oxygen species) production is altered by in utero programming, pregnant ewes were given a 48-h dexamethasone (dexamethasone-exposed, 0.28 mg.kg(-1) of body weight.day(-1)) or saline (control) infusion at 27-28 days gestation (term=145 days). Intact left ventricular mitochondria and freeze-thaw mitochondrial membranes were studied from offspring at 4-months of age. AmplexRed was used to measure H(2)O(2) production. Activities of the antioxidant enzymes Mn-SOD (manganese superoxide dismutase), GPx (glutathione peroxidase) and catalase were measured. Compared with controls, a significant increase in Complex I H(2)O(2) production was found in intact mitochondria from dexamethasone-exposed animals. The treatment differences in Complex I-driven H(2)O(2) production were not seen in mitochondrial membranes. Consistent changes in H(2)O(2) production from Complex III in programmed animals were not found. Despite the increase in H(2)O(2) production in intact mitochondria from programmed animals, dexamethasone exposure significantly increased mitochondrial catalase activity, whereas Mn-SOD and GPx activities were unchanged. The results of the present study point to an increase in the rate of release of H(2)O(2) from programmed mitochondria despite an increase in catalase activity. Greater mitochondrial H(2)O(2) release into the cell may play a role in the development of adult disease following exposure to an adverse intrauterine environment.
authors.affiliation: Department of Pediatrics, Carver College of Medicine, 200 Hawkins Drive, University of Iowa, Iowa City, IA 52242, USA.
authors.forename: Nicholas H
authors.initials: NH
authors.lastname: von Bergen
authors.forename: Stacia L
authors.initials: SL
authors.lastname: Koppenhafer
authors.forename: Douglas R
authors.initials: DR
authors.lastname: Spitz
authors.forename: Kenneth A
authors.initials: KA
authors.lastname: Volk
authors.forename: Sonali S
authors.initials: SS
authors.lastname: Patel
authors.forename: Robert D
authors.initials: RD
authors.lastname: Roghair
authors.forename: Fred S
authors.initials: FS
authors.lastname: Lamb
authors.forename: Jeffrey L
authors.initials: JL
authors.lastname: Segar
authors.forename: Thomas D
authors.initials: TD
authors.lastname: Scholz
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000502:physiology; D004195:Disease Models, Animal; D042967:Electron Transport Complex I / Q000378:metabolism; D014450:Electron Transport Complex III / Q000378:metabolism; D005260:Female; D047109:Fetal Development / Q000502:physiology*; D006861:Hydrogen Peroxide / Q000378:metabolism; D008297:Male; D008929:Mitochondria, Heart / Q000378:metabolism*; D051336:Mitochondrial Membranes / Q000378:metabolism; D010085:Oxidative Phosphorylation; D010101:Oxygen Consumption / Q000502:physiology; D017382:Reactive Oxygen Species / Q000378:metabolism*; D012756:Sheep
chemical_list: D000975:Antioxidants; D017382:Reactive Oxygen Species; D006861:Hydrogen Peroxide; D042967:Electron Transport Complex I; D014450:Electron Transport Complex III